Literature DB >> 32098704

Exogenous hydrogen sulfide inhibits human melanoma cell development via suppression of the PI3K/AKT/ mTOR pathway.

Qing Xiao1, Jiayi Ying1, Zhuhui Qiao1, Yiwen Yang1, Xiaoxi Dai1, Zhongyi Xu1, Chengfeng Zhang2, Leihong Xiang3.   

Abstract

BACKGROUND: Melanoma is one of the most aggressive, therapy-resistant skin cancers in the world. Hydrogen sulfide (H2S), a newly discovered gasotransmitter, plays a crucial role in the progression and development of many types of cancers. However, the effect of H2S on human skin melanoma remains to be elucidated.
OBJECTIVE: We aimed to explore the effect of exogenous H2S on melanoma cells and its underlying mechanisms.
METHODS: In this study, human skin melanoma cell lines, including A375 and SK-MEL-28, were treated with a donor of H2S (NaHS). CCK-8, scratch assay, flow cytometric analysis, western blotting and transmission electron microscopy (TEM) were performed to explore the effects of H2S on cell behaviors.
RESULTS: Treatment with NaHS inhibited cell proliferation, migration and division, while it could induce cell apoptosis and autophagy in melanoma cell lines. Moreover, NaHS significantly decreased the expression of p-PI3K, p-Akt and mTOR proteins. Furthermore, insulin-like growth factor-1 (IGF-1), the activator of PI3K/AKT/mTOR pathway, could reverse the cell behaviors caused by NaHS.
CONCLUSION: Our results demonstrated that exogenous hydrogen sulfide could inhibit human melanoma cell development via suppression of the PI3K/AKT/mTOR pathway. Hydrogen sulfide might serve as a potential therapeutic option for melanoma.
Copyright © 2020 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hydrogen sulfide; Melanoma; PI3K/AKT/ mTOR pathway

Mesh:

Substances:

Year:  2020        PMID: 32098704     DOI: 10.1016/j.jdermsci.2020.02.004

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  2 in total

Review 1.  Hydrogen Sulfide in Skin Diseases: A Novel Mediator and Therapeutic Target.

Authors:  Qing Xiao; Lidan Xiong; Jie Tang; Li Li; Li Li
Journal:  Oxid Med Cell Longev       Date:  2021-04-20       Impact factor: 6.543

2.  A20 promotes melanoma progression via the activation of Akt pathway.

Authors:  Jinyuan Ma; Huina Wang; Sen Guo; Xiuli Yi; Tao Zhao; Yu Liu; Qiong Shi; Tianwen Gao; Chunying Li; Weinan Guo
Journal:  Cell Death Dis       Date:  2020-09-23       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.